Opportunity Information: Apply for RFA AR 22 002
The Core Centers for Clinical Research (CCCR) (P30) - Clinical Trial Not Allowed funding opportunity (RFA-AR-22-002) is a National Institutes of Health (NIH) discretionary grant mechanism designed to support centralized, shared research infrastructure through a P30 core center award. As a reissue of the CCCR program, its main purpose is to strengthen and coordinate clinical research capacity by building and sustaining core resources that multiple investigators can use, rather than funding stand-alone, single-project research studies. The emphasis is on creating an organized center structure that improves efficiency, quality, and collaboration across clinical research efforts within an institution or consortium, typically by providing shared services, facilities, expertise, and governance that individual labs or research teams would struggle to maintain on their own.
A key restriction is captured in the title: clinical trials are not allowed under this opportunity. In practice, that means applicants should not propose activities that meet NIH's definition of a clinical trial, such as prospectively assigning human participants to an intervention to evaluate effects on health-related outcomes. Instead, the grant is oriented toward enabling and improving clinical research environments and shared capabilities. Typical P30-style center elements often include administrative leadership, oversight and governance, shared clinical or translational resources, biostatistics or data management support, recruitment or community engagement capacity, regulatory support, informatics, training or enrichment activities, and other core services that facilitate rigorous clinical research without proposing a trial itself as the funded activity.
Eligibility is broad and includes many U.S.-based organization types across government, academia, nonprofit, and industry. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized governments; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding institutions of higher education when specified); for-profit organizations other than small businesses; and small businesses. The opportunity also explicitly calls out additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISI); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible agencies of the federal government; regional organizations; and U.S. territories or possessions. Together, this reflects NIH's intent to allow a wide range of institutions, including those serving historically underrepresented communities, to compete for center infrastructure funding.
At the same time, there are important limits related to foreign involvement. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed. This distinction typically means a U.S. institution must be the applicant and primary awardee, while certain defined foreign collaborations or components may be included if they are justified, appropriately structured, and compliant with NIH policy. In other words, the grant is primarily meant to build U.S.-based center capacity, but it can still support specific foreign component activities when permitted under NIH rules.
From the administrative details provided, this opportunity is cataloged under CFDA number 93.846 and is issued by the National Institutes of Health. The original closing date listed is September 13, 2021, and the opportunity was created on March 19, 2021. The listed award ceiling is $500,000, indicating an upper bound on the amount that may be awarded (often per year, though the precise interpretation depends on the full announcement and budget period structure). The expected number of awards is not specified in the provided data. Overall, the CCCR (P30) program is best understood as NIH support for shared clinical research cores and center governance that enable multiple research projects and investigators, with the explicit requirement that the funded center activities themselves must not include clinical trials.Apply for RFA AR 22 002
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Core Centers for Clinical Research (CCCR) (P30)- Clinical Trial Not Allowed" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.846.
- This funding opportunity was created on 2021-03-19.
- Applicants must submit their applications by 2021-09-13. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Program to Advance the Career Development of Scientists from Diverse Backgrounds Conducting Nutrition, Obesity, Diabetes, and Related Research (U24 Clinical Trial Optional)
Previous opportunity: Cooperative Agreement for CESU-affiliated Partner with USGS Rocky Mountain Cooperative Ecosystem Studies Unit
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AR 22 002
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AR 22 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer's Disease and Related Dementias (R25 - Clinical Trial Not Allowed) Apply for RFA AG 22 010 Funding Number: RFA AG 22 010 Agency: National Institutes of Health Category: Health Funding Amount: $139,000 |
| Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Aging (R25 - Clinical Trial Not Allowed) Apply for RFA AG 22 009 Funding Number: RFA AG 22 009 Agency: National Institutes of Health Category: Health Funding Amount: $139,000 |
| Limited Competition: Alzheimers Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed) Apply for PAR 21 212 Funding Number: PAR 21 212 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional) Apply for RFA AT 21 006 Funding Number: RFA AT 21 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00) Apply for PAR 21 143 Funding Number: PAR 21 143 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed) Apply for RFA RM 21 022 Funding Number: RFA RM 21 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed) Apply for RFA RM 21 021 Funding Number: RFA RM 21 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial Not Allowed) Apply for RFA HG 21 007 Funding Number: RFA HG 21 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed) Apply for RFA AI 21 009 Funding Number: RFA AI 21 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial Not Allowed) Apply for RFA HG 21 006 Funding Number: RFA HG 21 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44) Apply for RFA HG 21 008 Funding Number: RFA HG 21 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 21 012 Funding Number: RFA AI 21 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD's Mentoring Networks to Enhance Clinician-Scientists' Participation in Research (R25 Clinical Trial Not Allowed) Apply for PAR 21 187 Funding Number: PAR 21 187 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2 Clinical Trial Not Allowed) Apply for RFA AR 21 016 Funding Number: RFA AR 21 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases, and Sjgrens Syndrome (UC2 Clinical Trial Optional) Apply for RFA AR 21 015 Funding Number: RFA AR 21 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) Apply for PAR 21 210 Funding Number: PAR 21 210 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required) Apply for PAR 21 211 Funding Number: PAR 21 211 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed) Apply for PAR 21 196 Funding Number: PAR 21 196 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentoring Networks to Enhance Diversity in NIDCD's Extramural Research Workforce (R25 Clinical Trial Not Allowed) Apply for PAR 21 185 Funding Number: PAR 21 185 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 21 012 Funding Number: RFA RM 21 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AR 22 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
